These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 9987092

  • 1. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G.
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ, PʼNg CH, OʼConnell PJ, Chapman JR.
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [Abstract] [Full Text] [Related]

  • 3. Molecular and structural consequences of early renal allograft injury.
    Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [Abstract] [Full Text] [Related]

  • 4. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
    Koziolek MJ, Riess R, Geiger H, Thévenod F, Hauser IA.
    Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
    [Abstract] [Full Text] [Related]

  • 5. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR.
    Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
    [Abstract] [Full Text] [Related]

  • 6. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
    Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S.
    Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
    [Abstract] [Full Text] [Related]

  • 7. The kidney transplant program at the Bergamo Center.
    Remuzzi G, Perico N, Gotti E, Ruggenenti P, Rota G, Locatelli G.
    Clin Transpl; 2000 Dec; ():179-91. PubMed ID: 11512311
    [Abstract] [Full Text] [Related]

  • 8. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.
    Snanoudj R, Royal V, Elie C, Rabant M, Girardin C, Morelon E, Kreis H, Fournet JC, Noël LH, Legendre C.
    Am J Transplant; 2011 Dec; 11(12):2635-46. PubMed ID: 21883915
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine-induced renal dysfunction in experimental animals and humans.
    Remuzzi G, Perico N.
    Kidney Int Suppl; 1995 Dec; 52():S70-4. PubMed ID: 8587288
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine nephropathy: pathophysiology and clinical impact.
    Shihab FS.
    Semin Nephrol; 1996 Nov; 16(6):536-47. PubMed ID: 9125798
    [Abstract] [Full Text] [Related]

  • 11. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
    Gotti E, Perico N, Perna A, Gaspari F, Cattaneo D, Caruso R, Ferrari S, Stucchi N, Marchetti G, Abbate M, Remuzzi G.
    J Am Soc Nephrol; 2003 Mar; 14(3):755-66. PubMed ID: 12595513
    [Abstract] [Full Text] [Related]

  • 12. Modifying cyclosporine associated renal allograft dysfunction.
    Mohapatra N, Vanikar AV, Patel RD, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
    [Abstract] [Full Text] [Related]

  • 13. Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.
    Hazzan M, Hertig A, Buob D, Copin MC, Noël C, Rondeau E, Dubois-Xu YC.
    J Am Soc Nephrol; 2011 Jul; 22(7):1375-81. PubMed ID: 21719789
    [Abstract] [Full Text] [Related]

  • 14. Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.
    Bakker RC, Hollander AA, Mallat MJ, Bruijn JA, Paul LC, de Fijter JW.
    Kidney Int; 2003 Sep; 64(3):1027-34. PubMed ID: 12911553
    [Abstract] [Full Text] [Related]

  • 15. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.
    Mourad G, Vela C, Ribstein J, Mimran A.
    Transplantation; 1998 Mar 15; 65(5):661-7. PubMed ID: 9521200
    [Abstract] [Full Text] [Related]

  • 16. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
    Stallone G, Di Paolo S, Schena A, Infante B, Grandaliano G, Battaglia M, Gesualdo L, Schena FP.
    Transplantation; 2003 Apr 15; 75(7):998-1003. PubMed ID: 12698087
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine microemulsion formulation (sigmasporin microral) effect as first-line immunosuppressant on renal functions at 3 years.
    Al Wakeel J, Shaheen FA, Al Alfi A, Abbas Fagir EH, Iman A, Nampoory MR, Al Mousawi MS, Said T, Abou Zeinab H, Shaker DS, Ghaedi BB.
    Transplant Proc; 2012 Jan 15; 44(1):94-100. PubMed ID: 22310589
    [Abstract] [Full Text] [Related]

  • 18. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice.
    Park HS, Kim EN, Kim MY, Lim JH, Kim HW, Park CW, Yang CW, Jin DC, Choi BS.
    Transpl Immunol; 2016 Feb 15; 34():42-9. PubMed ID: 26603313
    [Abstract] [Full Text] [Related]

  • 19. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
    Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S.
    J Am Soc Nephrol; 2006 Jan 15; 17(1):305-12. PubMed ID: 16306168
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
    Thervet E, Morelon E, Ducloux D, Bererhi L, Noël LH, Janin A, Bedrossian J, Puget S, Chalopin JM, Mihatsch M, Legendre C, Kreis H.
    Clin Transplant; 2000 Dec 15; 14(6):561-6. PubMed ID: 11127309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.